J3401 – Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ3401
- Long description
- Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
- Short description
- Vyjuvek 5x10^9pfu/ml, 0.1 ml
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2024
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code J3401?
J3401 is a HCPCS Level II code for beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml.
Does Medicare cover J3401?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J3392 – Injection, exagamglogene autotemcel, per treatment
- J3393 – Injection, betibeglogene autotemcel, per treatment
- J3394 – Injection, lovotibeglogene autotemcel, per treatment
- J3396 – Injection, verteporfin, 0.1 mg
- J3397 – Injection, vestronidase alfa-vjbk, 1 mg
- J3398 – Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
- J3399 – Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
- J3400 – Injection, triflupromazine hcl, up to 20 mg
- J3402 – Injection, remestemcel-l-rknd, per therapeutic dose
- J3403 – Revakinagene taroretcel-lwey, per implant
- J3404 – Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
- J3405 – Injection, onasemnogene abeparvovec-brve, per treatment
- J3406 – Injection, omidubicel-onlv, per therapeutic dose
- J3410 – Injection, hydroxyzine hcl, up to 25 mg
- J3411 – Injection, thiamine hcl, 100 mg
- J3415 – Injection, pyridoxine hcl, 100 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.